# The Veterinary Medicines Regulations 2013, Paragraph 1: Interpretation

Extent: E+W+S

(1) In this Schedule—
...
“pharmaceutical product” means any veterinary medicinal product other than an immunological product or a biological veterinary medicinal product that is not immunological;
“simultaneous application” is an application in which, at the time an authorisation for a product is applied for, one or more additional applications are submitted for products that are identical to the first product except that—
(a)in the case of an immunological product, they have a lesser number of antigens than the first product, but only contain antigens contained in the first product; and
(b)in the case of a pharmaceutical product, they have different strengths of the active substance,
...
(2) For the purposes of this Schedule “manufacturing authorisation” means the following activities—
(a) manufacture or import of an authorised veterinary medicinal product;
(b) manufacture of a product to which paragraph 2 of Schedule 6 relates;
(c) manufacture of a product for administration under the cascade;
(d) manufacture of—
(i) an autogenous vaccine;
(ii) a stem cell product; or
(iii) a blood product for administration to non-food animals.

---
Source: https://www.legislation.gov.uk/uksi/2013/2033/schedule/7/paragraph/1 (the official version)
Page: https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-7/paragraph-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.